Patient Care

Health Catalyst Signs Definitive Agreement to Acquire Upfront Healthcare Services

SALT LAKE CITY, Jan. 13, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and…

11 months ago

OrthoNebraska Selects Health Catalyst Ignite™ to Advance Data-Driven Orthopedic Care

SALT LAKE CITY, Jan. 13, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and…

11 months ago

New Standard for Medtech Alternate Equipment Management (AEM)

AAMI Document Clarifies Repair RequirementsArlington, VA, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Alternate equipment management (AEM) plans for medical devices…

12 months ago

Universal Brain Announces Publication of Groundbreaking Depression Research Using Multiple Event-Related Potentials

New findings support the company's neuroscience-driven approach to precision psychiatry, offering actionable insights for personalized depression treatment PALO ALTO, Calif.,…

12 months ago

VSee Health Secures Major Contract with Leading Florida Health System to Deliver Home Health and TeleNursing

Driving Healthcare Innovation and Growth Across Hospitals and CommunitiesSAN JOSE, Calif.--(BUSINESS WIRE)--VSee Health, Inc. (Nasdaq: VSEE), a leader in comprehensive…

12 months ago

PharmD On Demand + 340B

Unlocking Significant Savings for Rural Hospitals WATKINSVILLE, GA / ACCESSWIRE / January 10, 2025 / Did you know there is…

12 months ago

Navigating the Future of Physician Practice Management – Key 2025 Trends From Black Book Surveys

TAMPA, FLORIDA / ACCESSWIRE / January 10, 2025 / As the medical industry adapts to rapid regulatory changes, operational challenges,…

12 months ago

NCCN Guidelines Updated to Include ctDNA-MRD Testing Recommendation for B-Cell Lymphoma

BOULDER, Colo., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Foresight Diagnostics, a leader in ultra-sensitive minimal residual disease (MRD) detection technology,…

12 months ago

scPharmaceuticals Provides Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results

Preliminary unaudited fourth quarter 2024 net revenue expected to be approximately $12 million to $12.3 million, representing 99% growth over…

12 months ago

NewAmsterdam Pharma Highlights 2024 Achievements and Outlines 2025 Strategic Priorities

-- Additional data from BROADWAY, BROOKLYN, and TANDEM to be presented throughout 2025; expected to support global regulatory filings for…

12 months ago